Encompass Health Corporation (EHC)
NYSE: EHC · IEX Real-Time Price · USD
82.47
-0.26 (-0.31%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Encompass Health Revenue

In the year 2023, Encompass Health had annual revenue of $4.80B with 10.41% growth. Revenue in the quarter ending December 31, 2023 was $1.25B with 9.63% year-over-year growth.

Revenue (ttm)
$4.80B
Revenue Growth
+10.41%
P/S Ratio
1.72
Revenue / Employee
$127,147
Employees
37,761
Market Cap
8.26B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.80B452.60M10.41%
Dec 31, 20224.35B333.70M8.31%
Dec 31, 20214.01B448.60M12.58%
Dec 31, 20203.57B-1.04B-22.56%
Dec 31, 20194.61B327.70M7.66%
Dec 31, 20184.28B363.40M9.28%
Dec 31, 20173.91B271.30M7.45%
Dec 31, 20163.64B526.90M16.91%
Dec 31, 20153.12B741.40M31.23%
Dec 31, 20142.37B127.10M5.66%
Dec 31, 20132.25B112.30M5.26%
Dec 31, 20122.13B129.00M6.43%
Dec 31, 20112.01B144.70M7.77%
Dec 31, 20101.86B76.30M4.27%
Dec 31, 20091.78B-44.60M-2.44%
Dec 31, 20081.83B106.00M6.15%
Dec 31, 20071.72B28.00M1.65%
Dec 31, 20061.70B-55.40M-3.16%
Dec 31, 20051.75B-1.66B-48.65%
Dec 31, 20043.41B-248.19M-6.79%
Dec 31, 20033.66B-246.00M-6.30%
Dec 31, 20023.90B350.83M9.87%
Dec 31, 20013.55B54.22M1.55%
Dec 31, 20003.50B-573.27M-14.08%
Dec 31, 19994.07B66.03M1.65%
Dec 31, 19984.01B882.90M28.27%
Dec 31, 19973.12B474.99M17.94%
Dec 31, 19962.65B529.51M24.99%
Dec 31, 19952.12B469.48M28.47%
Dec 31, 19941.65B669.99M68.42%
Dec 31, 1993979.21M514.92M110.90%
Dec 31, 1992464.29M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AptarGroup 3.49B
Bio-Rad Laboratories 2.67B
Chemed 2.26B
Qiagen 1.97B
Stevanato Group 1.21B
Penumbra 1.06B
Ascendis Pharma 296.35M
Legend Biotech 285.14M
Revenue Rankings